Bempedoic acid (ETC-1002)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bempedoic acid (ETC-1002), covering 2020-04-03 to 2020-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C [Phase 2]